Physician profile
David Jassir
NPI 1861492340
$3,290.05
in general payments reported to CMS, 2019-2025
19 companies · $1,016 in 2025
The $1,016 reported for 2025 was more than what 80% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $188 · 2020: $222 · 2021: $306 · 2022: $392 · 2023: $502 · 2024: $663 · 2025: $1,016.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,182.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $929.48 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $647.09 | 2021-2025 | Dupixent |
| Optinose US, INC. | $566.47 | 2019-2025 | |
| Alk-Abello, INC | $328.18 | 2019-2023 | Grastek, Ragwitek, Odactra |
| Glaxosmithkline, LLC. | $292.27 | 2021-2025 | Nucala |
| Kaleo, INC. | $111.39 | 2020-2024 | Auvi-Q |
| Medtronic, INC. | $90.87 | 2024-2025 | Propel, Nuvent, Sinuva |
| Aerin Medical INC. | $53.69 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $42.63 | 2022-2023 | |
| Smith+Nephew, INC. | $39.03 | 2019-2020 | |
| Acclarent, INC | $38.76 | 2022 | |
| Intersect Ent, INC. | $34.71 | 2019 | |
| Ars Pharmaceuticals Operations, INC. | $22.32 | 2025 | Neffy |
| Paratek Pharmaceuticals, INC. | $18.90 | 2025 | Xhance |
| Hikma Pharmaceuticals USA | $17.27 | 2024 | Ryaltris |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $16.30 | 2025 | Inspire |
| Olympus America INC. | $16.00 | 2023 | Rhino-Laryngo Videoscope |
| Stryker Corporation | $14.36 | 2020 | |
| Kerecis Limited | $10.33 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Jassir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.